Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR4 | P22455 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 7/20 | 0.41 |
| ▸ | BTK | Q06187 | 2/20 | 0.41 |
| ▸ | WEE1 | P30291 | 7/20 | 0.41 |
| ▸ | CCNT1 | O60563 | 2/20 | 0.41 |
| ▸ | CDK9 | P50750 | 2/20 | 0.41 |
| ▸ | CDK4 | P11802 | 1/20 | 0.40 |
| ▸ | CCND1 | P24385 | 1/20 | 0.40 |
| ▸ | FGFR1 | P11362 | 4/20 | 0.40 |
| ▸ | SRC | P12931 | 2/20 | 0.38 |
| ▸ | JAK3 | P52333 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30879233 | 0.90 | WEE1 (0.52) | FGFR4EGFRWEE1CCNT1CDK9 | |
| SCHEMBL30878353 | 0.89 | FGFR4 (0.47) | FGFR4EGFRBTKWEE1CCNT1 | |
| SCHEMBL30879105 | 0.86 | FGFR1 (0.46) | FGFR4EGFRBTKWEE1CCNT1 | |
| SCHEMBL30879282 | 0.86 | FGFR1 (0.42) | FGFR4EGFRWEE1CCNT1CDK9 | |
| SCHEMBL30879066 | 0.85 | FGFR1 (0.48) | FGFR4EGFRBTKWEE1CCNT1 | |
| SCHEMBL30879162 | 0.85 | EGFR (0.48) | FGFR4EGFRBTKWEE1CDK4 | |
| SCHEMBL30879118 | 0.85 | WEE1 (0.42) | FGFR4EGFRBTKWEE1CCNT1 | |
| SCHEMBL30878874 | 0.84 | FGFR1 (0.43) | FGFR4EGFRBTKWEE1CCNT1 | |
| SCHEMBL30879314 | 0.84 | CCNT1 (0.44) | FGFR4EGFRBTKWEE1CCNT1 | |
| SCHEMBL30878727 | 0.83 | EGFR (0.50) | FGFR4EGFRBTKCDK4CCND1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4612148-A1 | 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER | Cancer Research Technology Limited (GB) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024094963-A1 | 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2024-05-10 | — | — | WO | disclosed |